Since nearly 85% of breast cancer patients were ER positive and recent results showed that ER transcription factors are strongly associated with breast cancer metastasis and invasion, we finally selected Chidamide for subsequent analysis of MCF-7 cells. This evidence concerns the gene ESR1 and breast carcinoma.